Articles From: Cementos Pacasmayo S.A.A. Announces Its Annual Shareholders’ Meeting Agenda to Cenovus oil production climbs 15% in first quarter

Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“Cementos Pacasmayo” or the “Company”) in accordance with CONASEV Resolution for Material Events, Reserved Information and Other Communications N° 107-2002-EF/94.10, announces the following: Cementos Pacasmayo’s Board of Directors, in its session held February 15, 2013, agreed unanimously to call an Annual Shareholders’ Meeting, to be held at Calle La Colonia No 150, Urb.

Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“Cementos Pacasmayo” or the “Company”) ”) a leading Peruvian cement company announced today that at the Annual Shareholders’ Meeting held March 26, 2013 at 10:00 am (Peruvian time), approved by majority vote the following: About Cementos Pacasmayo S.A.A. Cementos Pacasmayo S.A.A. is a leading Peruvian cement company, and the only cement manufacturer in the Northern region of Peru.

Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“Cementos Pacasmayo” or “the Company”), a leading Peruvian cement company, will host an Investor Luncheon at the New York Stock Exchange-Euronext on Tuesday, March 19, 2013 from 12:30 p.m. to 2:30 p.m. The event will feature a presentation by senior management, followed by a question and answer session.

CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today the pricing of U.S.$600 million aggregate principal amount of senior secured notes (the “Notes”) denominated in U.S. dollars.

CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE:CX) , announced today that as a result of the application of retained earnings for a capital increase approved by CEMEX’s shareholders at the general ordinary shareholders meeting held on March 21, 2013, CEMEX shareholders will receive new shares as follows: The delivery of the new CPOs or shares, as applicable, will be made starting on April 26, 2013.

CEMEX S.A.B. de C.V. (NYSE: CX) announced today the winners of INTEGRATE , the company’s Global Suppliers Innovation Program.

CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE:CX) , announced today that it has filed its annual report for the fiscal year ended December 31, 2012 on Form 20-F with the United States Securities and Exchange Commission (the "SEC"). The annual report on Form 20-F is available on CEMEX’s website via the following link:  http://www.cemex.com/InvestorCenter/files/2012/CEMEX2012_20F.pdf and is also available on the SEC website at http://www.sec.gov .

CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) announced today that, during 2012, it provided building solutions for the completion of 315 infrastructure projects —representing more than 8 million square meters of pavement for highways, mass transit projects, airport runways, and city streets.

CEMEX, S.A.B. de C.V. ("CEMEX") (NYSE: CX) , announced today that consolidated net sales reached U.S.$3.3 billion during the first quarter of 2013, a decrease of 5% versus the comparable period in 2012.

CEMEX, S.A.B. de C.V. ("CEMEX") (NYSE: CX) , announced today that for the full year 2012, operating EBITDA increased by 10% to US$2.6 billion, with net sales reaching US$15.0 billion a decline of 2% on a year-over-year basis.

CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE:CX) announced today a collaboration agreement with the Earth Engineering Center (EEC) at Columbia University and City College of New York in which EEC will conduct a year-long study of the life cycle effects of using alternative fuels in cement manufacturing.

CEMEX, S.A.B. de C.V. (NYSE: CX) announced today that it will host a full-day video webcast presentation on Thursday, February 14, 2013, starting at 8:25AM EST in which members of senior management will discuss the company’s business and financial strategy, operations in its different regions, outlook and other related topics, which may contain important information for CEMEX’s stakeholders.

CEMEX, S.A.B. de C.V. (“CEMEX”) (NYSE: CX) presented today its 2012 Sustainable Development Report.

BELO HORIZONTE, Brazil , May 2, 2013 /PRNewswire/ -- COMPANHIA ENERGETICA DE MINAS GERAIS – CEMIG ("Cemig"), a listed company with securities traded on the stock exchanges of Sao Paulo , New York and Madrid , hereby informs the public, in accordance with its commitment to best corporate governance practices, and of CVM Instruction 358 of January 3, 2002 , that it filed, on April 29, 2013 , the "Form 20-F" annual report for the year ended December 31, 2012 with the United States Securities and Exchange Commission ("SEC"). The report may be accessed on the sites of the SEC ( www.sec.gov ) and from Cemig's Investor Relations Department ( http://ri.cemig.com.br ) in the section Financial Information - SEC Filings.

- Phase 2 study of patients with gonococcal infections shows 100 percent were treated successfully - Solithromycin is active against Mycoplasma genitalium, a pathogen that is increasingly resistant to treatment with any antibiotic - Solithromycin demonstrates superior activity to azithromycin against Legionella pneumophila, a serious pnuemonia pathogen - Solithromycin demonstrates activity against enterococci, a pathogen with few treatment options CHAPEL HILL, N.C. , April 26, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) , a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it will present data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Berlin , demonstrating solithromycin's potential to treat urogenital infections and combat challenging pathogens such as enterococci and

- Company to Host Conference Call and Webcast at 4:30 p.m. EDT, Today, Apr.

- Company to Host Conference Call and Webcast at 4:30 p.m. EST, Today, Feb.

- Cempra to Host Conference Call and Webcast at 4:30 p.m. EDT, Today, May 13, 2013 - CHAPEL HILL, N.C. , May 13, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) , a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical needs in the treatment of bacterial infections, today announced the signing of an exclusive license and development agreement for solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation in Japan .

CHAPEL HILL, N.C. , April 24, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes , Ph.D., president and chief executive officer of Cempra, will present at the 12 th Annual Needham Healthcare Conference at 1:40 p.m. EDT , Wednesday, May 1 , at the Westin New York Grand Central Hotel in New York .

CHAPEL HILL, N.C. , Feb.

CHAPEL HILL, N.C. , Feb.

CHAPEL HILL, N.C. , April 18, 2013 /PRNewswire/ -- Cempra, Inc.  (Nasdaq: CEMP) today announced that it will report first quarter 2013 financial results and provide a business update after the close of U.S. financial markets on April 25, 2013.

CHAPEL HILL, N.C. , Feb.

SANTIAGO, Chile , April 26, 2013 /PRNewswire/ -- Cencosud (NYSE: CNCO, BCS: CENCOSUD) a leading South American retailer with operations in Chile , Argentina , Brazil , Peru and Colombia , today announced the results of its Annual Shareholder Meeting.

SANTIAGO, Chile , May 7, 2013 /PRNewswire/ -- Cencosud (NYSE: CNCO, BCS: CENCOSUD) a leading South American retailer with operations in Chile , Argentina , Brazil , Peru and Colombia , today announced that the company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2012 with the Securities and Exchange Commission (SEC). The report is available online at the SEC website www.sec.gov .

Revenue rose 18% YoY to CLP 2,581 billion EBITDA rose 16% YoY to CLP 247,182 million SANTIAGO, Chile , March 1, 2013 /PRNewswire/ -- Cencosud S.A. (NYSE: CNCO) , a leading multi-format Latin American retailer with presence in five countries, announced today its consolidated financial results for the fourth quarter of 2012.

Cenovus files 2012 year-end disclosure documents Canada NewsWire CALGARY , Feb.

CALGARY , Feb.

Refining operating cash flow increases 97% to $524 million Cash flow was $971 million , or $1.28 per share in the first quarter, an increase of 7% from the same period in 2012, mainly due to strong performance from the company's refining business.

Cenovus oil production climbs 15% in first quarter Canada NewsWire Refining operating cash flow increases 97% to $524 million Cash flow was $971 million , or $1.28 per share in the first quarter, an increase of 7% from the same period in 2012, mainly due to strong performance from the company's refining business.